Clinical Trial Update: Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9 [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating immunogenicity of one dose of Gardasil and one dose of Gardasil-9.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Genital Warts
• Human Papillomavirus Infection
• Oropharyngeal Cancer
• Vaginal Cancer

Drugs mentioned

• Gardasil (human papillomavirus vaccine)
• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Laval University | Conditions: Human Papillomavirus Vaccines | Phase 3 | Status: COMPLETED